1. The Role of Genetic Polymorphism and Other Factors on Clopidogrel Resistance (CR) in an Asian Population with Coronary Heart Disease (CHD)
   Mohammed Ahmed Akkaif et al, 2021, Molecules CrossRef
2. Pharmacogenetic variants of CYP2C9 and CYP2C19 associated with adverse reactions induced by antiepileptic drugs used in Peru
   Angel T. Alvarado et al, 2023, Pharmacia CrossRef
3. Role of Genetic Polymorphisms of Cytochrome P450 2C19 in Pantoprazole Metabolism and Pantoprazole-based Helicobacter pylori Eradication Regimens
   Paulius Jonaitis et al, 2020, Current Drug Metabolism CrossRef
4. Characterization of CYP2C19*17 Polymorphism in a Portuguese Population Sample Relevant for Proton Pump Inhibitor Therapy—A Pilot Study
   Adriana Ferraz et al, 2021, The 5th International Congress of CiiEM (IC CiiEM) CrossRef
5. Assessment of omeprazole and famotidine effects on the pharmacokinetics of tacrolimus in patients following kidney transplant–randomized controlled trial
   Miłosz Miedziaszczyk et al, 2024, Frontiers in Pharmacology CrossRef
6. Drug-disease interaction: Clinical consequences of inflammation on drugs action and disposition
   Yasmeen El Hajj Abdallah et al, 2023, Journal of Pharmacy & Pharmaceutical Sciences CrossRef
7. Utility of the ACD-GENE-CLI Score in Asian Patients with Critical Limb Ischemia Undergoing Endovascular Interventions
   Wei-Ting Chang et al, 2023, Journal of Atherosclerosis and Thrombosis CrossRef
8. The Cytochrome P450 2C19 Polymorphism Associated with Major Adverse Cardiovascular Events Risk in Kazak Patients Undergoing Percutaneous Coronary Intervention and Receiving Clopidogrel
   Hongjian Li et al, 2023, Endocrine, Metabolic & Immune Disorders - Drug Targets CrossRef
9. The role of clopidogrel resistance-related genetic and epigenetic factors in major adverse cardiovascular events among patients with acute coronary syndrome after percutaneous coronary intervention
   Astuti Giantini et al, 2023, Frontiers in Cardiovascular Medicine CrossRef
10. Prevalence of five pharmacologically most important CYP2C9 and CYP2C19 allelic variants in the population from the Republic of Srpska in Bosnia and Herzegovina
    Stojko Vidović et al, 2021, Archives of Industrial Hygiene and Toxicology CrossRef
11. Frequency of CYP2B6 Alleles in Major Iranian Ethnicities, Affecting Response to Efavirenz
    Parham Mardi et al, 2022, Genetics Research CrossRef
12. Influence of CYP2D6, CYP2C19 and CYP3A5 polymorphisms on plasma levels of tamoxifen metabolites in Algerian women with ER+ breast cancer
    Amira Boucenna et al, 2022, Egyptian Journal of Medical Human Genetics CrossRef
13. MicroRNA as Potential Biomarkers of Platelet Function on Antiplatelet Therapy: A Review
    Pamela Czajka et al, 2021, Frontiers in Physiology CrossRef
14. Allelic and Genotype Frequencies of CYP2B6∗2 (64C > T) and CYP2B6∗3 (777C > A) in Three Dominant Ethnicities of the Iranian Population
    Armin Khavandegar et al, 2023, Genetics Research CrossRef
15. Detection of CYP2C19*2_ allele among Helicobacter pylori -infected patients in two tertiary hospitals of Khartoum, Sudan, 2019
    Azza Abbas et al, 2021, F1000Research CrossRef
16. The Prevalence of Allele Frequencies of CYP2C19 Polymorphisms of Clinically Important Drug-Metabolizing Enzymes CYP2C19 in Moldova Healthy Population
    Marta Dogot et al, 2024, 6th International Conference on Nanotechnologies and Biomedical Engineering CrossRef
17. Analysis of the Potential Association of Drug-Metabolizing Enzymes CYP2C9*3 and CYP2C19*3 Gene Variations With Type 2 Diabetes: A Case-Control Study
    Imadeldin Elfaki et al, 2020, Current Drug Metabolism CrossRef